FMTI: My pick for quote of the day:
"It's disappointing," said Karen Boodram, a biotechnology analyst at Pacific International Securities in Vancouver, British Columbia.
Boodram said the company must now try to position the treatment for the alternative market. "There is still value, but not value as a blockbuster," she added.
Drugs receive the blockbuster designation when it is determined that they could generate more than US$1 billion in annual sales.
"Illegitimacy is something we should talk about in terms of not having it."
- Dan Quayle